Methicillin-resistant Staphylococcus aureus without borders: USA300 in Cuba
© Hopman et al; licensee BioMed Central Ltd. 2011
Published: 29 June 2011
Introduction / objectives
Methicillin-resistant Staphylococcus aureus (MRSA) is an increasing problem in the Americas and the Caribbean including Cuba. Recently, MRSA isolates are emerging as significant pathogens in the community. In the USA, the most prevalent community associated (CA-)MRSA clone is USA300 (ST8, spa type 008). Little is known about the molecular epidemiology of MRSA in some of the Caribbean countries. In this study we aim to investigate the molecular epidemiology of MRSA isolates from 4 major Cuban hospitals.
During a 3 months period in 2008 all clinical isolates suspected to be MRSA were prospectively collected. Three major Cuban hospitals and the national reference centre for infectious diseases participated in the study. Oxacillin susceptibility testing was performed in Cuba. Further examinations were done in the Netherlands, including Panton-Valentine leukocidin(PVL), genes lukS-lukV, mecA and Spa-typing.
From the 56 suspected Staphylococcus isolates, 38 were confirmed to be MRSA. Spa typing identified 5 different spa-types. In decreasing frequency we found Spa-type t149, t008, t037, t4088 and t2029, in respectively 22, 8, 6, 1 and 1 isolates. Only the eight t008 isolates were PVL positive.
Here we report the first molecular typing results of MRSA isolates from Cuba. The predominant clone was the Spa-type 149, followed by CA-MRSA USA300. We conclude that an economic and political embargo is a weak infection control measurement to contain the spreading of a potentially harmful pathogen.
Disclosure of interest
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.